Investigated parameter | Control Group | AKG Group | HMB Group | AH Group |
---|---|---|---|---|
(n = 12) | (n = 12) | (n = 12) | (n = 12) | |
Osteocalcin (ng/mL) | 24.0 ab | 28.5 a | 23.9 ab | 16.5 b |
± 3.7 | ± 4.2 | ± 3.5 | ± 3.4 | |
Bone alkaline phosphatase activity (U/L) | 20.9 a | 28.8 b | 27.9 b | 26.4 b |
± 1.4 | ± 1.6 | ± 1.3 | ± 1.9 | |
Growth hormone (ng/mL) | 18.1 a | 23.4 ab | 28.0 bc | 34.1 c |
± 1.9 | ± 2.6 | ± 1.9 | ± 3.2 | |
Insulin-like growth factor-1 (μg/L) | 49.1 a | 97.9 b | 73.8 c | 113.2 b |
± 4.8 | ± 9.5 | ± 2.9 | ± 10.8 |